What are the possible causes of neutrophilia with lymphopenia?

High Neutrophils, Low Lymphocytes: Possible Causes

The combination of neutrophilia with lymphopenia most commonly indicates acute bacterial infection, severe systemic inflammation, or corticosteroid effect, though the specific etiology depends critically on clinical context including medication exposure, underlying malignancy, and infection risk.

Primary Diagnostic Considerations

Infection-Related Causes

Acute bacterial infection is the most common cause of this pattern in clinical practice. The neutrophilia represents bone marrow response and demargination of neutrophils to combat infection, while lymphopenia occurs through redistribution of lymphocytes away from peripheral blood to lymphoid tissues and sites of inflammation 1, 2.

• Severe bacterial infections (pneumonia, sepsis, pyelonephritis, cholangitis) typically show marked neutrophilia (>10,000/mcL) with left shift
• Endotoxin and inflammatory cytokines (TNF-alpha, IL-1) directly cause lymphocyte redistribution from circulation 1
• In COVID-19 and severe viral infections, this pattern predicts worse outcomes - lymphopenia <0.5×10⁹/L increases mortality risk 12-fold 3

Medication-Induced Causes

Corticosteroid administration is a leading iatrogenic cause that clinicians must actively exclude through medication history 4.

• Corticosteroids cause neutrophilic leukocytosis by impairing neutrophil migration to inflammatory sites and promoting demargination
• Simultaneously induce lymphocytopenia (particularly T-cells) through redistribution to bone marrow and lymphoid tissues
• This effect occurs within hours of administration and is dose-dependent
• The pattern can persist with chronic steroid use

Malignancy-Associated Causes

In patients with hematologic malignancies, this pattern carries specific implications 5, 6:

• Neutropenia (not neutrophilia) is more typical in acute leukemia and after chemotherapy
• However, reactive neutrophilia can occur with:
  • Tumor necrosis and secondary infection
  • G-CSF administration for neutropenia management
  • Underlying myeloproliferative disorders
• Lymphopenia is common in:
  • Chronic lymphocytic leukemia (CLL) - especially with multiple prior treatments 5
  • Lymphomas receiving chemotherapy
  • Post-stem cell transplantation 7

Hypogammaglobulinemia frequently coexists with lymphopenia in hematologic malignancies and independently increases infection risk (OR 1.85 for any infection, OR 2.43 for sepsis) 6.

Autoimmune and Inflammatory Conditions

Systemic lupus erythematosus (SLE) demonstrates distinct patterns 8:

• Isolated neutropenia occurs in 13.3% of patients
• Isolated lymphopenia occurs in 13.3%
• Both abnormalities coexist in 11.6%
• Lymphopenia associates with male sex, anti-Smith antibodies, and immunosuppressive therapy
• Most cytopenias are mild; severe neutropenia is rare

Active pericarditis and other inflammatory conditions show neutrophilia with lymphopenia during acute flares 9:

• Neutrophil count correlates positively with C-reactive protein
• Lymphocyte count correlates negatively with inflammation markers
• Higher neutrophil-to-lymphocyte ratio (NLR) predicts multiple recurrences

Clinical Approach Algorithm

Step 1: Assess Clinical Context

• Fever, signs of infection? → Pursue infectious workup (cultures, imaging)
• Medication review → Corticosteroids, immunosuppressants, chemotherapy
• Known malignancy? → Consider disease-related vs. treatment-related causes
• Autoimmune disease history? → Evaluate for disease flare

Step 2: Quantify the Abnormality

• Neutrophil count >10,000/mcL suggests acute infection or inflammation
• Lymphocyte count <0.5×10⁹/L indicates severe immunosuppression with high mortality risk 3
• Calculate NLR (neutrophil-to-lymphocyte ratio) - elevated values predict poor outcomes in infection and inflammation 9, 10

Step 3: Risk Stratification for Infection

In neutropenic patients (ANC <500/mcL), assess infection risk 11:

• Low risk: Expected neutropenia <7 days, solid tumors → No prophylaxis needed
• Intermediate risk: Neutropenia 7-10 days, lymphoma, autologous transplant → Consider fluoroquinolone prophylaxis
• High risk: Neutropenia >10 days, acute leukemia, allogeneic transplant → Fluoroquinolone prophylaxis recommended

Step 4: Evaluate for Underlying Causes

Laboratory workup should include:

• Complete blood count with differential and review of peripheral smear
• Comprehensive metabolic panel
• C-reactive protein, ESR
• Blood cultures if febrile
• Immunoglobulin levels if hematologic malignancy or recurrent infections 6
• Autoimmune serologies if clinically indicated (ANA, anti-dsDNA, anti-Smith) 8

Critical Pitfalls to Avoid

1. Missing corticosteroid effect: Always obtain complete medication history including recent steroid bursts, inhalers, or topical preparations

2. Underestimating infection risk: Severe lymphopenia (<0.5×10⁹/L) dramatically increases mortality even with normal or elevated neutrophils 3

3. Assuming neutrophilia excludes neutropenia risk: In cancer patients on chemotherapy, current neutrophilia may precede profound neutropenia within 48 hours 11

4. Overlooking hypogammaglobulinemia: In hematologic malignancies, check immunoglobulin levels as this independently predicts infection risk beyond cell counts 6

5. Ignoring signs of inflammation in neutropenic patients: Fever may be the only sign of serious infection when neutrophils are absent; inflammatory markers and symptoms may be blunted 12

6. Delaying empiric antibiotics: In febrile neutropenic patients, even with current neutrophilia, immediate broad-spectrum antibiotics are critical (temperature ≥38.3°C or ≥38.0°C for 1 hour defines fever requiring treatment) 12